{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:18:36Z","timestamp":1759483116254},"reference-count":27,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4223,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Eosinophilia and allergic skin reactions are uncommon events after 2\u2010chlorodoxyadenosine (2\u2010CdA, cladribine) administration. A multicentre retrospective analysis of eosinophilia in 360 patients treated with 2\u2010CdA for lymphoid malignancies has been made. B\u2010cell chronic lymphocytic leukaemia (B\u2010CLL) was diagnosed in 153, hairy cell leukaemia (HCL) in 68, low\u2010grade non\u2010Hodgkin's lymphoma (LGNHL) in 119, high\u2010grade NHL in 2 and Waldenstr\u00f6m's macroglobulinaemia (WM) in 18 patients. 2\u2010CdA was administered at a dose 0.12 mg\/kg\/d in 2\u2010h intravenous infusion for 5 consecutive d. The courses were repeated monthly. Patients with HCL received 1 cycle of 2\u2010CdA, with NHL 2 \u2013 6 (mean 3.5) cycles and with B\u2010CLL 3 \u2013 6 (mean 5) cycles. Twenty patients (5.5%), including 5 with HCL, 6 with LGNHL, 7 with B\u2010CLL and 2 with WM, developed peripheral blood eosinophilia. The mean values of absolute eosinophil count were 0.78\u00d710<jats:sup>9<\/jats:sup>\/l (0.58 \u2013 1.06\u00d710<jats:sup>9<\/jats:sup>\/l), 0.71\u00d710<jats:sup>9<\/jats:sup>\/l (0.52 \u2013 1.3\u00d710<jats:sup>9<\/jats:sup>\/l), 85 (0.56 \u2013 1.82\u00d710<jats:sup>9<\/jats:sup>\/l) and 0.75 (0.74 \u2013 0.76\u00d710<jats:sup>9<\/jats:sup>\/l), respectively. Eosinophilia occurred in 13 patients after 1 course, in 4 after 2 courses, and in 5 after \u22653 courses of the therapy. In 17 cases it resolved spontaneously. Allergic skin lesions with pruritus were noticed in 3 patients simultaneously with an increase in eosinophil count. All of them required antihistaminic drugs and\/or corticosteroids. One patient with B\u2010CLL experienced repeated episodes of eosinophilia. The highest incidence of 2\u2010CdA\u2010induced eosinophilia was noticed in patients with MW (11.1%) and HCL (7.4%) who received only 1 cycle of this drug and entered a complete remission. This side effect was less frequently observed in LGNHL and B\u2010CLL, i.e. in 5.0% and 4.6% of cases, respectively. The mechanism of 2\u2010CdA\u2010induced eosinophilia is not clear. It has been postulated that massive tumour cell lysis may trigger a release of IL\u20105 and probably other cytokines. The allergic mechanism of 2\u2010CdA\u2010induced eosinophilia is also possible, especially in patients with simultaneous skin reactions.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1997.tb00980.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T08:13:17Z","timestamp":1279440797000},"page":"216-220","source":"Crossref","is-referenced-by-count":13,"title":["2\u2010Chlorodeoxyadenosine (cladribine)\u2010related eosinophilia in patients with lymphoproliferative diseases"],"prefix":"10.1111","volume":"59","author":[{"given":"T.","family":"Robak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"B\u0142asi\u0144ska\u2010Morawiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Krykowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dmoszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Adamczyk\u2010Cioch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kazimierczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Trepi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dwilewicz\u2010Trojaczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Kuratowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Skotnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. S.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Zdziarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Urasi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.11.6865"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00333a046"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood.V62.4.737.737","article-title":"Specific toxicity of 2\u2010chloro\u2010deoxyadenosine toward resting and proliferating human lymphocytes","volume":"62","author":"Carson DA","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92826-2"},{"issue":"1","key":"e_1_2_1_6_2","first-page":"75","article-title":"Cladribine (2\u2010chlorodeoxyadenosine) in the treatment of haematologic malignancies","volume":"6","author":"Robak T.","year":"1996","journal-title":"Appl Biol Commun"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111710"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004193221605"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V79.4.888.bloodjournal794888","article-title":"Rapid recovering from cytopenia in hairy cell leukemia after treatment with 2\u2010chloro\u20102\u2032\u2010deoxyadenosine (CdA): relation to opportunistic infection","volume":"79","author":"Juliusson G.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.3.1069.bloodjournal7231069"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a010604"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609051736"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.3.371"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199709109163"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-9-199405010-00010"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346050-00007"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V83.10.2906.2906","article-title":"2\u2010Chlorode\u2010oxyadenosine suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia","volume":"83","author":"Seymour JF","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_18_2","first-page":"285","article-title":"Transient eosinophilia in a patient with hairy cell leukaemia treated with 2\u2010chlorodeoxyadenosine","volume":"23","author":"Robak T.","year":"1992","journal-title":"Acta Haematol Pol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.00869.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1845.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90367-4"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290307"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704023161401"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402243300804"},{"issue":"1","key":"e_1_2_1_27_2","first-page":"336","article-title":"2\u2010Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome: regression of eosinophilia and bone marrow fibrosis","volume":"88","author":"Reykdal S.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2340\/0001555576385386","article-title":"Cutaneous reactions after treatment with 2\u2010chlorodeoxyadenosine","volume":"76","author":"Meunier P.","year":"1996","journal-title":"Acta Derm Venerol"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1997.tb00980.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1997.tb00980.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T21:37:04Z","timestamp":1698442624000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1997.tb00980.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1111\/j.1600-0609.1997.tb00980.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1997.tb00980.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}